Kucinich’s Congressional Briefing Examines “Progress on Finding a Treatment for Ill Gulf War Veterans”
Kucinich Secured $29 Million to Fund Research
Washington,
Feb 2 -
Congressman Dennis Kucinich (D-OH) held a widely attended Congressional briefing to examine advancements in treating veterans who suffer from Gulf War Illness.
See Congressman Kucinich’s welcoming statement here.
Speaking at the briefing was Colonel Jeffery Leggit, Director of the Congressionally Directed Medical Research Programs with the Department of Defense; Dr. Roberta White, Chair of Environmental Health at the Boston University School of Public Health who chairs the advisory panel that determines what research is requested and funded; Mr. Anthony Hardie, a Gulf War veteran who serves on Dr. White’s committee; Dr. Beatrice Golomb of the University of California, San Diego, who recently completed the first successful pilot study for a treatment for one of the most serious symptoms of Gulf War Illness; and Dr. Lea Steele of Baylor University, former scientific director of the Research Advisory Committee on Gulf War Veterans Illnesses.
Congressman Kucinich has led the way in the Congress in advancing the search for treatments for the veterans suffering from Gulf War Illness. Over the last several years, Congressman Kucinich has secured $29 million dollars for the Gulf War Veterans Illness Research Program within the Congressional Directed Medical Research Programs to seek effective treatments for this disease that affects an estimated 250,000 veterans of the first Gulf War.
The Gulf War Veterans Illness Research Program, funded through efforts by Kucinich and others, is the only national program studying this issue, and it is working. Congressional Directly Medical Research Program -funded researchers at the University of California, San Diego, reported in June on the first successful medication treatment study in the history of Gulf War Illness research. The study showed that the supplement “CoQ10” produced significant improvement in one of the most serious symptoms of Gulf War illness, fatigue with exertion. The study needs be replicated in a larger group, but the result is extremely encouraging. The research conducted by GWVIRP is vital not only for ill Gulf War veterans, who currently lack any effective treatments, but also for other U.S. military forces.
Regulatory Affairs Subcommittee 
Education and Workforce Committee 
West Side Market 
Cleveland Skyline 
John Glenn Research Center 
